Global Immunohistochemistry Market

Immunohistochemistry Market Size, Share, Growth Analysis, By Product (Antibodies (Primary antibodies, Secondary antibodies) clonality (Monoclonal antibodies, Polyclonal antibodies), Reagents (Histological Stains), By Application (Diagnostic applications (Cancer, Infectious diseases, Autoimmune diseases, Nephrological diseases), By End-user (Hospitals & Diagnostic Laboratories, Academic Institutions & Contract Research Organizations (CROs), Other end users (Pharmaceutical & Biopharma Companies, and Forensic Laboratories)), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35H2224 | Region: Global | Published Date: September, 2024
Pages: 157 | Tables: 89 | Figures: 76

Immunohistochemistry Market Competitive Landscape

Investing in the development of immunohistochemistry-based diagnostics will be the most rewarding opportunity for any market player. Creating affordable immunohistochemistry solutions that can be used by establishments with limited budgets will help immunohistochemistry companies expand their business in developing countries going forward. New product launches and collaborations are slated to be popular strategies for all immunohistochemistry companies.

Immunohistochemistry Market Top Player’s Company Profiles

  • F. Hoffmann-La Roche Ltd. 
  • Danaher Corporation 
  • Agilent Technologies Inc. 
  • PHC Holdings Corporation 
  • Thermo Fisher Scientific Inc. 
  • Merck KGaA 
  • Bio-Rad Laboratories, Inc. 
  • Bio-Techne 
  • Becton, Dickinson and Company 
  • Takara Bio Inc. 
  • Enzo Biochem Inc. 
  • Sino Biological, Inc. 
  • Sakura Finetek Japan Co., Ltd. 
  • Cell Signaling Technology, Inc. 
  • BIO SB 
  • Miltenyi Biotec 
  • OriGene Technologies, Inc. 
  • EagleBio 
  • Biocare Medical, LLC 
  • Elabscience Bionovation Inc. 
  • BioGenex 
  • Diagnostic BioSystems Inc. 
  • Histo-Line Laboratories 
  • Rockland Immunochemicals, Inc. 
  • Candor Bioscience GmbH 
  • Genemed Biotechnologies, Inc.

Immunohistochemistry Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Immunohistochemistry Market size was valued at around USD 2.9 billion in 2022 and is expected to rise from USD 3.1 billion in 2023 to reach a value of USD 5.5 billion by 2031, at a CAGR of 7.4% over the forecast period (2024–2031).

Investing in the development of immunohistochemistry-based diagnostics will be the most rewarding opportunity for any market player. Creating affordable immunohistochemistry solutions that can be used by establishments with limited budgets will help immunohistochemistry companies expand their business in developing countries going forward. New product launches and collaborations are slated to be popular strategies for all immunohistochemistry companies. 'F. Hoffmann-La Roche Ltd. ', 'Danaher Corporation ', 'Agilent Technologies Inc. ', 'PHC Holdings Corporation ', 'Thermo Fisher Scientific Inc. ', 'Merck KGaA ', 'Bio-Rad Laboratories, Inc. ', 'Bio-Techne ', 'Becton, Dickinson and Company ', 'Takara Bio Inc. ', 'Enzo Biochem Inc. ', 'Sino Biological, Inc. ', 'Sakura Finetek Japan Co., Ltd. ', 'Cell Signaling Technology, Inc. ', 'BIO SB ', 'Miltenyi Biotec ', 'OriGene Technologies, Inc. ', 'EagleBio ', 'Biocare Medical, LLC ', 'Elabscience Bionovation Inc. ', 'BioGenex ', 'Diagnostic BioSystems Inc. ', 'Histo-Line Laboratories ', 'Rockland Immunochemicals, Inc. ', 'Candor Bioscience GmbH ', 'Genemed Biotechnologies, Inc.'

Immunohistochemistry plays a vital role in the diagnostics of multiple chronic diseases, and this is why as the prevalence of chronic diseases increases around the world it is also expected to influentially drive up the demand for immunohistochemistry products and technologies as well.  

Automation is projected to be a major trend across all industry verticals in the future. Development of automated immunohistochemistry solutions will also offer highly lucrative opportunities for all immunohistochemistry market players in the future. Use of artificial intelligence will play a vital role in promoting automation.

North America is projected to account for a dominant the global immunohistochemistry market share. The presence of a strong medical research infrastructure, supportive government funding for research, and rising demand for early diagnostics are forecasted to create new opportunities for immunohistochemistry market players. The United States is projected to lead the demand for immunohistochemistry in this region owing to the presence of multiple pharmaceutical and biotechnology companies in the country. Canada is also expected to provide lucrative opportunities for immunohistochemistry companies as demand for better diagnostic products increases.  

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Immunohematology Market
Buy Now GET FREE SAMPLE
Immunology Market
Buy Now GET FREE SAMPLE
Immunoassay Market
Buy Now GET FREE SAMPLE
Nutritional Immunology Market
Buy Now GET FREE SAMPLE
Immunodiagnostics Market
Buy Now GET FREE SAMPLE
Immunoglobulin Market
Buy Now GET FREE SAMPLE
Antibody Production Market
Buy Now GET FREE SAMPLE
Immuno-Oncology Drugs Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Immunohistochemistry Market

Report ID: SQMIG35H2224

$5,300
BUY NOW GET FREE SAMPLE